👤 Kaimi Li

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
3991
Articles
2551
Name variants
Also published as: Xiaocun Li, Jianyu Li, Xinzhi Li, Guanqiao Li, Zequn Li, Guang-Xi Li, Yubo Li, Bugao Li, Qingchao Li, Xikun Li, Hong-Tao Li, Guobin Li, Xihao Li, Rongqing Li, Chang-Da Li, Meng-Yue Li, DaZhuang Li, Shunqin Li, Jiajie Li, Yaqiong Li, Yuan-hao Li, Yongmei Li, X Y Li, Peilin Li, Ran Li, Chunshan Li, Yixiang Li, Guanglve Li, Ye Li, Zili Li, Yihao Li, Qing Run Li, Liling Li, Meng-Yang Li, Ziyun Li, Jun-Ying Li, Xinhai Li, Yongjiang Li, Wanru Li, Wenhao Li, Shisheng Li, Sai Li, Guangwen Li, Hua Li, Dongmei Li, Jiayang Li, Zunjiang Li, Minglong Li, Wenzhe Li, Zihan Li, Jin-Long Li, Hongxin Li, Caiyu Li, Fa-Hui Li, Guangpu Li, Teng Li, Wen-Jie Li, Hegen Li, Ang Li, Zhizong Li, Lu-Yun Li, Peng Li, Shiyu Li, Fang Li, Jiuke Li, Miyang Li, Mingxu Li, Chen-Xi Li, Panlong Li, Changwei Li, Biyu Li, Yaoqi Li, San-Feng Li, Jiaming Li, Jiyuan Li, Rongkai Li, Yani Li, Linke Li, C Y Li, Thomas Li, Siting Li, Yongnan Li, Jinchen Li, Jin-Ping Li, Xuewen Li, R Li, Xianlong Li, Aixin Li, Xuening Li, Guang Li, Xiaoming Li, Z-H Li, Yongli Li, Baohong Li, Shuyuan Li, L Li, Yuanmei Li, Yanwu Li, Hualing Li, Sibing Li, Xining Li, Qinghe Li, Zonghua Li, Liqin Li, Jingya Li, Youjun Li, Zheng-Dao Li, Zhenshu Li, Heng-Zhen Li, Yuhui Li, Wen-Ying Li, Wei Li, Shuanglong Li, Fei-feng Li, Letai Li, Kangli Li, Ming Li, Wenbo Li, Runwen Li, Yarong Li, Weidong Li, S E Li, Xin-Tao Li, Ruotong Li, Shuguang Li, Xiuzhen Li, Lingxi Li, Chuan-Hai Li, Tingting Li, Guanghua Li, Zhongyu Li, Zhen-Yu Li, Deyu Li, Hansen Li, Jinzhi Li, Yijing Li, Kaifeng Li, Wen-Xing Li, Qintong Li, Naishi Li, Xin-Ping Li, Han-Ni Li, Jiaying Li, Cui-lan Li, Ruonan Li, Jun-Jie Li, Shuhao Li, Ruitong Li, Suyan Li, Gen-Lin Li, Dianjie Li, Junhui Li, Ya-Jun Li, Xue Cheng Li, Ding-Biao Li, Xiying Li, Yansong Li, Weiyong Li, Xinyang Li, Cui Li, Xiaoyong Li, Y L Li, Xueyi Li, Jingxiang Li, Wenxue Li, Jianglin Li, Yingpu Li, Yan-Hua Li, Jing-Yao Li, Shawn Shun-Cheng Li, Xiao-Min Li, Wan Jie Li, Ya-Ting Li, Dongbiao Li, Keguo Li, Yuanfei Li, Longhui Li, Jing-Yi Li, Zhonghua Li, Chunyi Li, Peiyun Li, Qinglan Li, Yue-Ting Li, Da Li, YiPing Li, Demin Li, Haipeng Li, Chuan Li, Ze-An Li, Jianmin Li, Minhui Li, Yu Li, Yiwei Li, Xiangzhe Li, Minglun Li, Xue-Min Li, Kenneth Kai Wang Li, Chunlan Li, Chiyang Li, Hulun Li, Juan-Juan Li, Hua-Zhong Li, Jiaomei Li, Xiangyun Li, Jing Li, Yingshuo Li, Baixing Li, Dengke Li, Qingling Li, Rui-Han Li, Dong Li, Xiaoxia Li, Dezhi Li, Sheng-Jie Li, Ying-Qing Li, Xin-Jian Li, Guangxi Li, Yanhui Li, Sha-Sha Li, Mengxuan Li, Ziyu Li, Gang Li, Panyuan Li, Hong-Wen Li, Xiaojuan Li, Dongnan Li, Huaiyuan Li, Ji-Liang Li, Huaping Li, C H Li, Bohua Li, Pei-Ying Li, Shaobin Li, Ronald Li, Shilun Li, Shi-Hong Li, John Zhong Li, Xinyu Li, Lujiao Li, Song-Chao Li, Chenghong Li, Baohua Li, Nianfu Li, Jun-Cheng Li, Yimeng Li, Chunting Li, Chien-Feng Li, Mei-Zhen Li, Zhengjie Li, Liwei Li, Yan-Yan Li, Huijun Li, Chengyun Li, Lijun Li, Hening Li, Fengxia Li, Jialing Li, Xin Li, Ningyan Li, Zhenghui Li, Ailing Li, Chaochen Li, Tengyan Li, Xianlu Li, Jiaqi Li, Jiabei Li, Wenjing Li, Jingshu Li, Han-Bo Li, Zengyang Li, Chunyan Li, Runzhen Li, Xi-Hai Li, Xuezhong Li, MengGe Li, Pei-Lin Li, Wan-Xin Li, Ruobing Li, Ning Li, Meitao Li, Xia Li, Ziqiang Li, Wen-Xi Li, Shenghao Li, Hehua Li, Yucheng Li, Dujuan Li, Yuying Li, Shaofei Li, Shaoguang Li, Min-Rui Li, Shuqiang Li, Dan C Li, Huashun Li, Ganggang Li, Haoqi Li, Handong Li, Yan-Nan Li, Xianglong Li, Jing-Jing Li, Songhan Li, Conglin Li, Qingli Li, Miao Li, Chenyu Li, Ke Li, Zhen-Hua Li, Chuan-Yun Li, Gaoyuan Li, Youming Li, Qingrun Li, Dong-Yun Li, Shuangfei Li, Fengfeng Li, Qinggang Li, Huixia Li, Xingye Li, Xiangjun Li, Huiying Li, Xingyu Li, Zhaoping Li, Wenying Li, Honghui Li, Cheung Li, Xuelian Li, Zhenming Li, Changyan Li, Mulin Jun Li, Shangjia Li, Jingjing Li, Suhong Li, Xinping Li, Siyu Li, Guangzhen Li, Xiangyan Li, Shiyun Li, Xiaoyu Li, Yaobo Li, Xuewang Li, Mei Li, Manjiang Li, Wan Li, Xiao-Li Li, Xiaoya Li, Shan Li, Shitao Li, Zehan Li, Lijia Li, Huiliang Li, Chunqiong Li, Junjun Li, Hui-Long Li, Zhao-Cong Li, Zhi-Wei Li, Wenxi Li, Chang-hai Li, Yuqiu Li, Xue-Yan Li, Yuan-Yuan Li, Xiang-Jun Li, Chia Li, Y X Li, Yunyun Li, Zhen-Jia Li, Qiuxuan Li, De-Jun Li, Keqing Li, Junxian Li, Shuwen Li, Lingjun Li, Deheng Li, Si-Xing Li, Yaodong Li, Shigang Li, Gao-Fei Li, Minle Li, Le-Le Li, Ziwen Li, Yongqiu Li, Pu-Yu Li, Nan-Nan Li, Lan-Lan Li, Hongming Li, Shuang Li, Wanting Li, Gong-Hua Li, Zhengyu Li, Weiguang Li, Guoqing Li, Xiaomeng Li, Yuanze Li, Yunqi Li, Yuandong Li, Changcheng Li, Shiyue Li, Hanbo Li, Yinggao Li, Dingshan Li, Linlin Li, Jin-Wei Li, Cheng-Tian Li, Yaxi Li, Wei-Ming Li, Ming-Han Li, Wenchao Li, Guangyan Li, Zhaosha Li, Xuesong Li, Chun-Quan Li, Yongzhen Li, Tao Li, Xiankai Li, Yaxuan Li, Tian-wang Li, Yuchan Li, Jiaxi Li, Yalin Li, Pei-Zhi Li, Guanyu Li, Jinlan Li, Huizi Li, Jianping Li, Yun-Lin Li, Yadong Li, Sujing Li, Wenzhuo Li, Xuri Li, Mengqiu Li, Yun Li, Ling-Ling Li, Chengwen Li, Shu-Feng Li, Haojing Li, Zhiyu Li, Ziyang Li, Yaochen Li, Qian Li, Bohao Li, Wenyang Li, Wenming Li, Mingxuan Li, Bingsong Li, Anqi Li, Shuai Li, Xiaoju Li, Na Li, Huibo Li, Chuanfang Li, Pengsong Li, Ruotian Li, Chunya Li, En-Min Li, Zong-Xue Li, Yan Ning Li, Honglin Li, Min-jun Li, Jinhua Li, Qian-Qian Li, Yuanheng Li, Chunxiao Li, Shijun Li, Kuan Li, Baoguang Li, Jie-Shou Li, Zimeng Li, Mengmeng Li, W-B Li, Binkui Li, Yu-Sheng Li, Junjie Li, Xiaoqi Li, Xiucui Li, Haihua Li, Yu-Lin Li, Tsai-Kun Li, Shujing Li, Mengyun Li, Mingna Li, Lanlan Li, Moyi Li, Xiyun Li, Ya-Pei Li, Zhongjie Li, Zhenbei Li, Shuangshuang Li, Hongwei Li, Ding-Jian Li, Xiao-Qiang Li, Danni Li, Min Li, Pengyang Li, Kun-Xin Li, Xiangpan Li, Zesong Li, Mingfei Li, Shuwei Li, Mingdan Li, Xihe Li, Jianfeng Li, Dexiong Li, Rongsong Li, Yinxiong Li, Hong-Yu Li, Weijian Li, Changhui Li, Dechao Li, Wenxia Li, Guoxiang Li, Ziru Li, Juxue Li, Man Li, Huayin Li, Xiao-yu Li, Jianyi Li, Guowei Li, Xingya Li, Gongda Li, Yajun Li, Wei-Ping Li, Nanjun Li, P H Li, Ranran Li, Suping Li, Jason Li, Monica M Li, Xianlun Li, Qi Li, Xiaoli Li, Xionghui Li, Fei Li, Hongmei Li, Xu-Wei Li, Mengsen Li, Quanpeng Li, Yajiao Li, Qilan Li, Qiuhong Li, Zongyun Li, Xiao-Yun Li, Cheng-Lin Li, Yousheng Li, Wen-Ting Li, Guoping Li, A Li, Simin Li, Weiguo Li, Xue-Nan Li, Xiaoying Li, Shengsheng Li, Hong Li, Yuqi Li, Zihua Li, Qing Li, Jiaping Li, Weiyang Li, Feng Li, Peihong Li, Jin-Mei Li, Lisha Li, Cuicui Li, Kaibo Li, Hanbing Li, Meng-Hua Li, J T Li, Xiangwei Li, Baiqiang Li, Ziliang Li, Donghe Li, Zheng Li, Congfa Li, Wenrui Li, Yong Li, Xiuling Li, Jingqi Li, Zhiyong Li, Xiao-Kang Li, Hanqi Li, Yangyang Li, Dongfang Li, Zhuorong Li, X-H Li, Dong Sheng Li, Lan-Juan Li, Xianrui Li, Zhigao Li, Chenlin Li, Zihui Li, Guoli Li, Huanqiu Li, Zhan Li, Weisong Li, Xinglong Li, Xiaozhen Li, Zhiyang Li, Cunxi Li, Ying Li, Jianlin Li, Yanshu Li, Guiying Li, Jinku Li, Cuiling Li, Zhisheng Li, Changgui Li, Xuekun Li, Yuguang Li, Wenke Li, Jiayi Li, Suwen Li, Peihua Li, Chang-Ping Li, Guangda Li, Jieming Li, Chunhui Li, Tongyao Li, Peiyu Li, Linfeng Li, Yuzhe Li, Qifang Li, Chang-Yan Li, Xiaolin Li, Duanxiang Li, Vivian Li, Justin Li, Meiting Li, Xue-Er Li, Hongchang Li, Youwei Li, Ronggui Li, Xingwang Li, Tiange Li, Yongjia Li, Dacheng Li, Xinmin Li, Luquan Li, Guoxing Li, Jianyong Li, Zongchao Li, Jia Li, Haimin Li, Sheng-Qing Li, Lingjie Li, Yiwen Li, Baoqi Li, Leyao Li, Xiao-Qin Li, Jiajing Li, Yanlin Li, Liao-Yuan Li, Yongkai Li, Hangwen Li, Hengguo Li, An-Qi Li, Xuehua Li, AnHai Li, Chenli Li, Zhengrui Li, Rumei Li, Yan-Yu Li, Lipeng Li, Qinqin Li, Qinghua Li, Leilei Li, Lianyong Li, Zhou Li, Q Li, Bizhi Li, Cheng-Wei Li, Wenwen Li, Jian'an Li, Guangqiang Li, Sichong Li, Wenyi Li, Qing-Min Li, Meiyan Li, Yun-Da Li, Jian-Qiang Li, Yingrui Li, Chenfeng Li, Shen Li, Ziqi Li, Yunfeng Li, Shufen Li, Yueqi Li, Xiao-Guang Li, Jiali Li, Zhencheng Li, Qiufeng Li, Pinghua Li, Xu Li, Zhenli Li, Yunxiao Li, Rosa J W Li, Hsin-Yun Li, XiaoQiu Li, Zhankui Li, Zhi Li, Zhijie Li, Huimin Li, Ruifang Li, Xiao-xu Li, Man-Xiang Li, Cong Li, Chengbin Li, Yuping Li, G Li, Zhi-Yong Li, Yukun Li, Xiong Bing Li, Wen Lan Li, Qingjie Li, Han Li, Yutang Li, Hankun Li, Hongling Li, Zhifan Li, Yan-Guang Li, Ji-Min Li, Peipei Li, Tian-Yi Li, Zhihao Li, Yao Li, Zheyun Li, Zhonglin Li, Lin Li, Jinfang Li, Chenjie Li, Yanming Li, S L Li, Ben-Shang Li, Hong-Lan Li, Xionghao Li, Shunqing Li, Ming-Kai Li, Lan Li, Yanwei Li, Chien-Te Li, Wenyan Li, Xiaoheng Li, Zeyuan Li, Hongqin Li, Zhenhao Li, Jonathan Z Li, Yong-Liang Li, M Li, Jiehan Li, Hongguo Li, Chenxin Li, Yongsen Li, Qingyun Li, Pengyu Li, Ai-Qin Li, Zichao Li, Cien Li, Qingyu Li, Xijing Li, Jingshang Li, Xingyuan Li, Dehua Li, Yanjiao Li, Jia-Huan Li, Guoxi Li, Xudong Li, Xingfang Li, Jisheng Li, Rongyao Li, Ru Li, Jiangya Li, Yiche Li, Yilang Li, Yunshen Li, Jingchun Li, Hexin Li, H J Li, Yanping Li, Qing-Wei Li, Qiang Li, Hsiao-Hui Li, L I Li, Hongzheng Li, Laiqing Li, Ningyang Li, Zhongxia Li, Guangquan Li, Shun Li, Hui-Jun Li, Xuefei Li, Guojun Li, Hung Li, Senlin Li, Jinping Li, Sainan Li, Jinghui Li, Zulong Li, Chengsi Li, P Li, Fulun Li, Yonghao Li, Mingli Li, Yehong Li, Pei Li, Quanshun Li, Yongping Li, Liguo Li, Weimin Li, Mingxia Li, Xue-Hua Li, M V Li, Gan Li, Shichao Li, Dapei Li, Zejian Li, Lihong Li, Haixia Li, Jingmei Li, Ao Li, Yitong Li, Siwen Li, Yanlong Li, Zhao Li, Kui Li, Yunxu Li, Xuanfei Li, Zilin Li, Mingqiang Li, Xiaojiao Li, Yinzhen Li, Yunsheng Li, Li-Min Li, Xiangqi Li, Jia-Peng Li, Wenqi Li, Haibo Li, Xiao-Jun Li, Yan-Hong Li, Shi Li, Xueling Li, Conghui Li, Xiaoxiong Li, Wanni Li, Chitao Li, Haiyang Li, Xiaobai Li, Pingping Li, Mingquan Li, Suran Li, Yuanfang Li, Yingqin Li, Qiner Li, Jiafang Li, Shanhang Li, Han-Bing Li, Zongzhe Li, Yikang Li, Si-Yuan Li, Hongmin Li, Caihong Li, Yajing Li, Benyi Li, Yuquan Li, Hongzhi Li, Chengxin Li, Xiaojiaoyang Li, Xinxin Li, Jian-Shuang Li, Yubin Li, Dazhi Li, Chenglan Li, Yuhong Li, Fengqiao Li, Di Li, Yanbing Li, Jufang Li, Zecai Li, Qipei Li, Xiaoning Li, Xiyue Li, Minghua Li, Tianchang Li, Zhuoran Li, Hongru Li, Shiqi Li, Mei-Ya Li, Wuyan Li, Yi-Ling Li, Yingjian Li, Zhirong Li, Wang Li, Mingyang Li, Weijun Li, Boyang Li, Cai Li, Jingcheng Li, Ivan Li, Mengshi Li, Manxia Li, Ya Li, Dan-Ni Li, Wen-Chao Li, Sunan Li, Zhencong Li, Lai K Li, Jiong Li, Daiyue Li, Bingong Li, Chunxue Li, Yunlong Li, Jianshuang Li, Juanling Li, Xinbin Li, Xue-jing Li, Yuling Li, Yetian Li, Xianlin Li, Chuangpeng Li, Mingrui Li, Yanjun Li, Jiequn Li, Zhongding Li, Jiangui Li, Zhengyang Li, Cyril Li, Xinghui Li, Yuefei Li, Xinyan Li, Xiaoyun Li, Yushan Li, Ping'an Li, Weiping Li, Huan Li, Changjiang Li, Chengping Li, He-Zhen Li, G-P Li, Yinliang Li, Wen Li, Weihai Li, Yu-Kun Li, Jiangan Li, Zhaojin Li, Bingxin Li, Wenjuan Li, Chia-Yang Li, Wenyu Li, Hairong Li, Su Li, Mei-Lan Li, Wenjun Li, Jiaxin Li, Chenguang Li, Ming D Li, Ruyue Li, Xiaolian Li, Ya-Ge Li, Yinyan Li, Guangli Li, Rujia Li, Qijun Li, Lixia Li, Yunrui Li, Yuhuang Li, Shanshan Li, Wan-Shan Li, Jing-gao Li, Yiyang Li, Fengxiang Li, Nana Li, Jingui Li, Huamao Li, Xiankun Li, Jingke Li, Tianyao Li, Xiaowei Li, Junming Li, Hai-Yun Li, Zhongxian Li, H-J Li, Zhixiong Li, Lingyan Li, Xuhang Li, Chen-Lu Li, Jialun Li, Xinjian Li, Zilu Li, Sheng-Fu Li, Zezhi Li, Xue-Fei Li, Yudong Li, Hongjiang Li, Jingyun Li, Binghua Li, Hanjun Li, Qihua Li, Jin-Qiu Li, Jiaxuan Li, Guangjin Li, Xutong Li, Ranwei Li, Kai Li, Wei-Li Li, Keanning Li, Ling Li, Peiqin Li, Xiaodong Li, Nanxing Li, Qihang Li, Baoguo Li, Jianrong Li, Zhehui Li, Chenghao Li, Weike Li, Chuanbao Li, Zhixuan Li, Chuzhong Li, M D Li, Yuan-Tao Li, Kening Li, Guilan Li, Wanshi Li, Ling-Zhi Li, Hengtong Li, Yifan Li, Ya-Li Li, Songyun Li, Xiaoran Li, Bolun Li, Linchuan Li, Jiachen Li, Haibin Li, Huangbao Li, Guo-Chun Li, Xinli Li, S Li, Wenqing Li, Wenhua Li, Caiyun Li, Xinrui Li, Hanbin Li, Wanwan Li, Jia Li Li, Wan-Hong Li, Mingke Li, Huanhuan Li, Xiaoyuan Li, Zongfang Li, Yang Li, BoWen Li, Duoyun Li, Yimei Li, Zhi-qiang Li, Yi-Ting Li, Jiangxia Li, Yujie Li, Zhiping Li, Yan-Li Li, Haiming Li, Gaijie Li, Yuemei Li, Xuefeng Li, Xiao-Hong Li, Mengjuan Li, Yinglin Li, Yaofu Li, Ren-Ke Li, Yi Li, Baosheng Li, Mian Li, Yujun Li, Lixi Li, Jin-Xiu Li, Jiwen Li, Zhouhua Li, Qingqin S Li, Honglei Li, Guojin Li, Xin-Yue Li, Dingchen Li, Xiaoling Li, Meng-Jun Li, Peining Li, Congjiao Li, Huilin Li, Songtao Li, Fusheng Li, Dai Li, Meiyue Li, Kechun Li, Keshen Li, Yuxin Li, Shaoliang Li, Shu-Xin Li, Hong-Zheng Li, Tianye Li, Qun Li, Zhen Li, Mengling Li, Jia-Da Li, Baoqing Li, Pu Li, Xingli Li, Bingkun Li, Nien-Chi Li, Tiewei Li, Daniel Tian Li, Rong-Bing Li, Wei-Yang Li, Rong Li, Mingkun Li, Binxing Li, Zixiao Li, Guixin Li, Quanzhang Li, Da-wei Li, Xiumei Li, Melody M H Li, Peibo Li, Huanjun Li, Chung-Hao Li, Liuzheng Li, Zhanjun Li, Yifei Li, Tianming Li, Chang-Sheng Li, Tianyou Li, Jipeng Li, Longxuan Li, Shi-Guang Li, Wenxiu Li, Zhuang Li, Yu-Hao Li, Shilin Li, Shili Li, Meiqing Li, Hengyu Li, Yinhao Li, Junying Li, Mufan Li, Chun-Lai Li, Shiya Li, Xiao-Jiao Li, Li Li, Hanxue Li, Lulu Li, L P Li, Xiaoqin Li, Chunmei Li, Mingjun Li, Yuanhua Li, Qiaolian Li, Ji-Cheng Li, Haolong Li, Xuanzheng Li, Peng-li Li, Quan Li, Xue-Ying Li, Yongzhe Li, Tianyi Li, Qingfeng Li, Nanlong Li, Ping Li, Fangzhou Li, Nien-Chen Li, Yuanchuang Li, Haiying Li, Yunting Li, Hong-Yan Li, Shengbiao Li, Yue-Rui Li, Ruidong Li, Y M Li, Sijie Li, Meilan Li, D C Li, Andrew C Li, Jianye Li, Qiuyan Li, Tingguang Li, Xiangyang Li, Chunjie Li, Tianfeng Li, Anna Fen-Yau Li, Minghui Li, Jiangfeng Li, Jie-Pin Li, Kaiyi Li, Junyi Li, Dongtao Li, Fengyuan Li, Chenxi Li, Zuo-Lin Li, Zhengwei Li, Yan-Chun Li, Suiyan Li, Qiaoqiao Li, Xiaotian Li, Zhenguang Li, Jia-Ru Li, Pei-Qin Li, Chun-Xiao Li, Shu-Hong Li, Shuyue Li, Quan-Zhong Li, Tongzheng Li, Fangyan Li, Duo Li, Ren Li, Hongye Li, Lanfang Li, Mingwei Li, Wenxin Li, W J Li, Zhijia Li, Jingtong Li, Lucy Li, Zhengpeng Li, Xiayu Li, Baolin Li, Cuilan Li, Yuting Li, Xiaobo Li, Meijia Li, Shujiao Li, Kun-Ping Li, Weirong Li, Weihua Li, Runzhao Li, Xiang-Dong Li, Yanxin Li, Xiufeng Li, Yingjun Li, Xiaohuan Li, Ying-Qin Li, Fan Li, Jun Z Li, Yiheng Li, Taiwen Li, Xiaorong Li, Haifeng Li, Liping Li, Rena Li, Jiangtao Li, Yu-Jui Li, Rui-Jún Eveline Li, Xuanxuan Li, Bing-Mei Li, Yunman Li, Shuhua Li, Chunying Li, Leipeng Li, Weiheng Li, Baizhou Li, Han-Ru Li, Sheng Li, Yaqiang Li, Guoyin Li, Qiwei Li, Chengjun Li, Jianxiong Li, Ji Li, Huaying Li, Tuojian Li, Yixin Li, Ziyue Li, Juntong Li, Xiang Li, Chaonan Li, Yu-Chia Li, Heying Li, Shaomin Li, Yuxuan Li, Xuan-Ling Li, Bingshan Li, Jiahao Li, Shibao Li, Ruijin Li, Kunlong Li, Xiaofeng Li, Zhaolun Li, Litao Li, Ruyi Li, Wanxin Li, Jinsong Li, Ying-Lan Li, Yulin Li, Shaojian Li, Mohan Li, Yan-Xue Li, Enhong Li, Xiangnan Li, Yong-Jun Li, Hang Li, Ziming Li, Jing-Ming Li, Yuanchang Li, Xiao-Lin Li, Yicun Li, Zhao-Yang Li, K-L Li, Xinjia Li, Bin Li, Jianhai Li, Peiwu Li, Youran Li, Changyu Li, Ming Zhou Li, Z Li, Xinmei Li, Wulan Li, Haoxian Li, Xiaozhao Li, Da-Lei Li, Jinming Li, Huihui Li, Kailong Li, Qiankun Li, Shengxu Li, Xiuli Li, Yulong Li, Ru-Hao Li, Zhi-Peng Li, Lanzhou Li, Tingsong Li, Binjun Li, Chen Li, Yawei Li, Chao Bo Li, Donghua Li, Siming Li, Fengli Li, Song Li, Hsin-Hua Li, You Li, Dongfeng Li, Zhen-Yuan Li, Xuelin Li, Xueyang Li, Bao Li, Yin Li, Cai-Hong Li, Dejun Li, Yufeng Li, Miaoxin Li, Hu Li, Bei Li, W H Li, Sha Li, Ya-Qiang Li, Xiushen Li, Jinlin Li, Xiaoqing Li, Shuaicheng Li, Xuebiao Li, Yingyi Li, Maolin Li, Jiyang Li, Zhongxuan Li, Linting Li, Zhong-Xin Li, Enhao Li, Shengliang Li, Hujie Li, Yue-Ming Li, Zhaohan Li, Alexander Li, Wen-juan Li, Pilong Li, Yun-Peng Li, C X Li, Huanan Li, Miao X Li, KeZhong Li, Linying Li, Chu-Qiao Li, Fa-Hong Li, Changzheng Li, Yaokun Li, Zhi-Gang Li, Yufan Li, Liangqian Li, Guanghui Li, Xiongfeng Li, Side Li, Timmy Li, Jiezhen Li, Qiuya Li, Haitao Li, Yufen Li, Qin Li, Annie Li, Wenge Li, Xueren Li, Chun-Mei Li, Meng-Yao Li, Chung-I Li, Zhi-Bin Li, Junping Li, Xiao Li, PeiQi Li, Xiaobing Li, Liangdong Li, Yan Li, Shengchao A Li, Pan Li, Huiqiong Li, Guigang Li, Lucia M Li, Chunzhu Li, Chengquan Li, Zexu Li, Zhilei Li, Tiantian Li, Wenyong Li, Desen Li, Tianjun Li, Zihao Li, Fadi Li, Huawei Li, Yu-quan Li, Jihua Li, Jingping Li, Zhiquan Li, Zeyu Li, Zongdi Li, Ming V Li, Aowen Li, L K Li, Aimin Li, Tiehua Li, Guohong Li, Botao Li, L-Y Li, Xiuqi Li, Zhenhua Li, Zhengda Li, Haotong Li, Luhan Li, Yuancong Li, Tian Li, Yuxiu Li, Beibei Li, Changhong Li, Yvonne Li, Zhichao Li, Jiayuan Li, Yige Li, Siguang Li, Chengqian Li, Weiye Li, Dong-fei Li, Xiangchun Li, Hailong Li, Kun-Peng Li, Haijun Li, Si Li, Ji-Feng Li, Wanqian Li, Zijing Li, Wentao Li, Yuchuan Li, Xuhong Li, Hongyun Li, Zhonggen Li, Xiong Li, Penghui Li, Huiting Li, Xiaolong Li, Linqing Li, Jiawei Li, Defa Li, X L Li, Yuyan Li, Kawah Li, Shupeng Li, Zhenfei Li, Zhuo Li, Han-Wei Li, Weina Li, Xiao-Hui Li, Rui-Fang Li, Jianzhong Li, Bing Li, Huihuang Li, Yunmin Li, Yanying Li, Gui Lin Li, Chenrui Li, Dengfeng Li, N Li, Xiaotong Li, Chensheng Li, Ming-Qing Li, Yongxue Li, Bao-Shan Li, Zhimei Li, Jiao Li, Jingming Li, Jinxia Li, De-Tao Li, Shu Li, Julia Li, Huilan Li, Xin-Ya Li, Chunsheng Li, Chengjian Li, Ying-na Li, Guihua Li, Zhiyuan Li, Supeng Li, Yiju Li, Yuanhe Li, Guangxiao Li, Xueqin Li, Peixin Li, Feng-Feng Li, Zu-Ling Li, Yunjiu Li, Dayong Li, Zonghong Li, Lingjiang Li, Yuhan Li, Fuyuan Li, H-F Li, Chunxia Li, Zhen-Li Li, Zhengying Li, Zhaoshui Li, Yali Li, Yu-Hui Li, Chuang Li, Jiajun Li, Can Li, Zhe Li, Stephen Li, Shuangding Li, Mangmang Li, Kaiyuan Li, Xiaopeng Li, Anan Li, Luying Li, Jiajv Li, Xiaoquan Li, Yanxi Li, Yongjing Li, Huayao Li, Jiqing Li, Huixue Li, Boxuan Li, Yongqi Li, Qingyuan Li, Fengqi Li, Yuqing Li, Zhigang Li, Guiyang Li, Guo-Qiang Li, Yanbo Li, Sanqiang Li, Hongyu Li, Guangping Li, Jinxin Li, Xinrong Li, Yayu Li, Huaixing Li, Minyue Li, Hong-Mei Li, Jutang Li, Mengxia Li, Yongxiang Li, Qilong Li, Songlin Li, Dijie Li, Yizhe Li, Yan Bing Li, Jiani Li, Lianjian Li, Yiliang Li, Xinpeng Li, Hongxing Li, Wanyi Li, Mi Li, Guo Li, Jingxia Li, Xiu-Ling Li, Fuhai Li, Ruijia Li, Yumiao Li, Jiexi Li, Kecheng Li, Junxu Li, Junya Li, Jiang Li, Shengxian Li, Qingyang Li, Yuxi Li, Chenxuan Li, Xiao-Dong Li, Xinghuan Li, Zhenlu Li, Xiaolei Li, Huilong Li, Xiao-Gang Li, Zhenhui Li, Chunjun Li, Shu-Fen Li, Yinghua Li, Yanjie Li, Chaoying Li, Juanjuan Li, Qiu Li, Kunlun Li, Shiquan Li, Xiangdong Li, Zhenjia Li, Jifang Li, Zhizhong Li, Ding Yang Li, Chenlong Li, Shujin Li, Weining Li, Wu-Jun Li, Yumao Li, Bin-Kui Li, Honglian Li, Ya-Zhou Li, Hongyi Li, Fu-Rong Li, Honghua Li, Lanjuan Li, Man-Zhi Li, Xiancheng Li, Yanmei Li, Zhihua Li, Minqi Li, Saijuan Li, Danxi Li, Mimi Li, Yingjie Li, Yuan-Hai Li, Lujie Li, Minghao Li, Meifen Li, Yifeng Li, Huanqing Li, Yuhang Li, Jianhua Li, Chanjuan Li, Lingyi Li, Yanchuan Li, Bai-Qiang Li, Chunmiao Li, Jiong-Ming Li, Yongqiang Li, Linsheng Li, Mingyao Li, Ze Li, R H L Li, Guisen Li, Dongyang Li, Jinglin Li, Honglong Li, Mingfang Li, Hanmei Li, Chenmeng Li, Shiyang Li, Jianing Li, Xinsheng Li, Jin-Jiang Li, Zhi-Xing Li, Chang Li, Jiwei Li, Weifeng Li, Wenhui Li, Sichen Li, Qingsheng Li, Liangji Li, Lixiang Li, Jin-Liang Li, Xiaoqiong Li, You Ran Li, Yixiao Li, Kathy H Li, Yuhua Li, Deqiang Li, Y Li, Mingyue Li, Zipeng Li, Caixia Li, Hongli Li, Yanfeng Li, Yaqin Li, Yu-He Li, Shasha Li, S-C Li, Xi Li, Siyi Li, Minmin Li, Manna Li, Dawei Li, Xun Li, Ming-Jiang Li, Sitao Li, Tinghua Li, Zhenfen Li, Shuo Li, Si-Ying Li, Xinyi Li, Jenny J Li, Xue-zhi Li, Xiaonan Li, Zhenyu Li, Ting Li, Xiang-Yu Li, Duan Li, Lei Li, Hongde Li, Fengqing Li, Yanchang Li, Xunjia Li, Ruixia Li, Nanzhen Li, Hongxue Li, Bingjie Li, Xiaojing Li, Xinlin Li, Yu-Ying Li, Wenli Li, Mengze Li, Kaiwei Li, Huangyuan Li, Lili Li, Junxin Li, Wei-Jun Li, Guoyan Li, Fei-Lin Li, Nuomin Li, Yanyan Li, Shulin Li, Shanglai Li, Taibo Li, Yue Li, Junqin Li, JunBo Li, Jun-Ru Li, Xueying Li, Zhongcai Li, Zhaobing Li, Linxin Li, Jen-Ming Li, Chen-Chen Li, Hongquan Li, Chuan F Li, Yanxiang Li, Yi-Wen Li, Shihong Li, Rulin Li, Huifeng Li, Lijuan Li, Yuanhong Li, Shengbin Li, Jingyu Li, Xuewei Li, Long Li, Min-Dian Li, Wenjia Li, Xiatian Li, Yangxue Li, Chengnan Li, Chuanyin Li, Yiqiang Li, Zhenzhou Li, Xiawei Li, Binglan Li, Yutong Li, Yingnan Li, Ge Li, Xinzhong Li, Chenyao Li, Jun-Yan Li, Boru Li, Ruixue Li, Zemin Li, Jixi Li, Chris Li, Jicheng Li, Chuanning Li, Jiafei Li, Yingying Li, Gaizhi Li, Chien-Hsiu Li, Xiangcheng Li, Siqi Li, Chunxing Li, Qiao-Xin Li, Huang Li, Shu-Fang Li, Qiusheng Li, Weiqin Li, Xinming Li, Yongjun Li, Mengyang Li, Guo-Jian Li, Chenglong Li, Nan Li, Yipeng Li, Mingxing Li, Xin-Yu Li, Chunyu Li, Jinwei Li, Xuhua Li, Yu-Xiang Li, Long Shan Li, Yanze Li, Xiao-Feng Li, W Li, Fengjuan Li, Hainan Li, Yutian Li, Xiliang Li, Shuangmei Li, Ying-Bo Li, Duanbin Li, Maogui Li, Dan Li, Sumei Li, Peilong Li, Kang Li, Yinghao Li, Lirong Li, Wenhong Li, Audrey Li, Yijian Li, Guang Y Li, Xianyong Li, Shilan Li, Guang-Li Li, Bang-Yan Li, Enxiao Li, Jianrui Li, Guohua Li, Kezhen Li, Xingxing Li, Ellen Li, Yijie Li, Suwei Li, Shuyu D Li, Ruiwen Li, Jiandong Li, Fangyong Li, Binru Li, Yuchao Li, Hanlu Li, Jianang Li, Xue-Peng Li, Sheng-Tien Li, Shihao Li, Yazhou Li, Jun-Ling Li, Caesar Z Li, Lang Li, Feifei Li, Kejuan Li, Qinghong Li, Qiqiong Li, Xinxiu Li, Chongyi Li, Yi-Ying Li, Shaodan Li, Yongzheng Li, Da-Hong Li, Xiao-mei Li, Jiejie Li, Ruihuan Li, Yaoyao Li, Yueguo Li, Mo Li, Ming-Hao Li, Hongsen Li, Menghua Li, Ka Li, Kaixin Li, Fuping Li, Jianbo Li, Xing-Wang Li, Chong Li, Fugen Li, Yuwei Li, Xiaochen Li, Zizhuo Li, Xiaoxiao Li, Le-Ying Li, Pengcui Li, Bing-Heng Li, Xiaoman Li, Xiaohong Li, Yuan Hao Li, Jianchun Li, Wenxiang Li, Zhaoliang Li, Guo-Ping Li, Zhifei Li, Jinhui Li, Yuanyou Li, Chongyang Li, Wanyan Li, Yumin Li, Longyu Li, X B Li, Jianguo Li, En Li, Ximei Li, Shaoyong Li, Kai-Wen Li, Guandu Li, Yixue Li, Junfeng Li, Xin-Chang Li, Yue-Ying Li, Kongdong Li, Lian Li, Xinmiao Li, Chenyang Li, Jiacheng Li, Xiaohua Li, Zhuangzhuang Li, Xiaohui Li, Cang Li, Xuepeng Li, Mingjiang Li, Zongyu Li, Shujie Li, Yanbin Li, Shiliang Li, Qinrui Li, Yiming Li, Xiao-Tong Li, Tie Li, Wei-Bo Li, Xiaoyi Li, Liyan Li, Xinke Li, Xiaokun Li, Ming-Wei Li, Minzhe Li, Wenfeng Li, Karen Li, X Li, Meifang Li, Yanjing Li, Maosheng Li, Ju-Rong Li, Shibo Li, Jin Li, Li-Na Li, Hui Li, Fangqi Li, Xiaoguang Li, Xian Li, Danjie Li, Vivian S W Li, Ranchang Li, Defu Li, Amy Li, Haoyu Li, Xiaoyao Li, M-J Li, Jiao-Jiao Li, Zhu Li, Rongling Li, Tong-Ruei Li, Ben Li, Yingxia Li, Yonghe Li, Xinwei Li, Yu-I Li, Shunhua Li, Mingxi Li, Qionghua Li, Guo-Li Li, Xingchen Li, Tianjiao Li, Gui-Rong Li, Yunpeng Li, Qiong Li, Songyu Li, Shi-Fang Li, Shude Li, Zhibin Li, Yaxiong Li, Qing-Fang Li, Shengwen Li, Gui-Bo Li, Xueer Li, Zihai Li, Yue-Jia Li, Haihong Li, Peifen Li, Mingzhou Li, Taixu Li, Jiejing Li, Meng-Miao Li, Meiying Li, Chunlian Li, Meng Li, Cun Li, T Li, Yinghui Li, Feilong Li, Sin-Lun Li, Weiling Li, Mengfan Li, Jie Li, Shiyan Li, Lianbing Li, Yanchun Li, Xuze Li, Jialin Li, Wenjian Li, He Li, Bichun Li, Hanqin Li, Guoge Li, Wen-Wen Li, Keying Li, Minze Li, Xingcheng Li, Wanshun Li, Congxin Li, Xiangrui Li, Caolong Li, Michelle Li, Chaojie Li, J Li, Zhi-Jian Li, Jianwei Li, Jiexin Li, Hongyan Li, Zhen-Xi Li, Guangdi Li, Xiaxia Li, Nien Li, Yuefeng Li, Peiyuan Li, Tiansen Li, Chi-Yuan Li, Xiangfei Li, Xue Li, Fen Li, Jieshou Li, Roger Li, Mengqing Li, Menglu Li, Huiqing Li, Yantao Li, Ruolin Li, Yongle Li, Haying Li, Shao-Dan Li, Muzi Li, Gen Li, Dong-Ling Li, Chenwen Li, Le Li, Yong-Jian Li, Si-Wei Li, Manru Li, Yingxi Li, Caili Li, Yuqian Li, Wei-Dong Li, Guannan Li, Ya-Feng Li, Wenlong Li, Yuna Li, Shengli Li, Shugang Li, Xuan Li, Yongze Li, Yongxin Li, Lu Li, Zhuo-Rong Li, Qinglin Li, Bingbing Li, Runzhi Li, Qi-Jing Li, Zhenyan Li, Ji Xia Li, Yu-Ye Li, Meizi Li, Yuezheng Li, Zhengnan Li, Jianglong Li, Xiaozheng Li, Huili Li, Hongzhe K Li, Xiao-Qiu Li, Jiejia Li, Yi-Yang Li, Zhihui Li, Fujun Li, Ni Li, Luxuan Li, Qiang-Ming Li, Yakui Li, Huafu Li, Xinye Li, Chunliang Li, Ruiyang Li, Chun Li, Jianan Li, Wenfang Li, Xiangling Li, Sung-Chou Li, Lianhong Li, Cheng Li, Tiegang Li, Zhong Li, Shuang-Ling Li, Xiao-Long Li, Xiaofei Li, Hung-Yuan Li, Zhang Li, Jianxin Li, H Li, Dongliang Li, Chenxiao Li, Hongjia Li, Xiao-Jing Li, Y H Li, Jian Li, Daoyuan Li, Baichuan Li, Zhenzhe Li, Jian-Mei Li, Peiran Li, Qiao Li, Yi-Yun Li, Xiao-Cheng Li, Yike Li, Yihan Li, Junsheng Li, Jiayu Li, Wen-Ya Li, Rongxia Li, Yunlun Li, Guoqin Li, Huiqin Li, Chunlin Li, Jisen Li, Peng Peng Li, Kenli Li, Guanglu Li, Xiushi Li, Dongmin Li, Jian-Jun Li, Fengyi Li, Yanling Li, Juanni Li, C Li, You-Mei Li, Beixu Li, Guiyuan Li, Suk-Yee Li, Shengjie Li, Yuanyuan Li, Xiaona Li, Shanyi Li, Chih-Chi Li, Hongbo Li, Xinhui Li, Jun Li, Mingzhe Li, Hongjuan Li, Senmao Li, Mingjie Li, Ling-Jie Li, Hong-Chun Li, Yaying Li, Liqun Li, Changxian Li, Chunqing Li, Yanni Li, Yongsheng Li, Xiujuan Li, Huifang Li, Lingling Li, Xinhua Li, Minerva X Li, Alexander H Li, Wendeng Li, Ding Li, Ming-Yang Li, Shengze Li, Linyan Li, Hewei Li, Da-Jin Li, Xiao-kun Li, Yuanhao Li, Ji-Lin Li, Congcong Li, Juan Li, Xiaobin Li, Shaoqi Li, Yuehua Li, Jinfeng Li, Shiheng Li, Hsiao-Fen Li, Mengjiao Li, Tianxiang Li, Meng-Meng Li, Liangkui Li, Tian-chang Li, Yahui Li, Wenlei Li, Xi-Xi Li, Haiyan Li, Xujun Li, Chi-Ming Li, Yi-Ning Li, Dandan Li, Yunan Li, Sherly X Li, Jiazhou Li, Zhijun Li, Zechuan Li, Wanling Li, Zhiwei Li, Xueshan Li, Jiangbo Li, Xiaohan Li, Huijie Li, Zhongwen Li, W W Li, Yalan Li, Xuejun Li, Shunwang Li, Yaqing Li, Chao Li, Yaqiao Li, Bingsheng Li, Jianfang Li, Shubo Li, Qi-Fu Li, Zi-Zhan Li, Haoran Li, Xiaoliang Li, Xinyuan Li, Maoquan Li, Chumei Li, Shijie Li, Zhanquan Li, Wenguo Li, Fangyuan Li, Xiaochun Li, Rui Li, Xuemin Li, Shanpeng Li, Wei-Na Li, Dong-Run Li, Yunxi Li, Xuyi Li, Yunchu Li, Zhengyao Li, Jinghao Li, Y-Y Li, Xiaofang Li, Tuoping Li, Pengyun Li, Lin-Feng Li, Ziqing Li, Shuangxiu Li, Yongjin Li, Chenhao Li, Weizu Li, Deming Li, Jiuyi Li, Chun-Xu Li, Luyao Li, Desheng Li, Long-Yan Li, Fuyu Li, Lingzhi Li, Xiao-Sa Li, Kunlin Li, Shu-Qi Li, Zehua Li, Mengyuan Li, Congye Li, Wensheng Li, Dehai Li, Qingshang Li, Jiannan Li, Guanbin Li, Zhiyi Li, Xing Li, Zhaoyong Li, SuYun Li, Shiyi Li, Suchun Li, Yanan Li, Jiayan Li, YueQiang Li, Xiangping Li, H-H Li, Jinman Li, Dongdong Li, Hao Li, Liliang Li, Mengxi Li, Keyuan Li, Shaojing Li, S S Li, Tong Li, Yilong Li, Lihua Li, Xue-Lian Li, Yansen Li, Hai Li, Zhi-Yuan Li, Jingfeng Li, Yanli Li, Yuan-Jing Li, Kaibin Li, Xiaohu Li, Wenjie Li, Ruikai Li, Qiyong Li, Ruixi Li, Zhonglian Li, Dalin Li, Kun Li, Qizhai Li, Pengju Li, Peifeng Li, Ai-Jun Li, Yueting Li, YaJie Li, Zijian Li, Yanqing Li, Jixuan Li, Zhandong Li, Xuejie Li, Gaizhen Li, Liang Li, Huafang Li, Nianyu Li, Chenlu Li, X-L Li, Shawn S C Li, Cuiguang Li, Dongye Li, F Li, Chunhong Li, Yuan Li, Kunpeng Li, Zhenghao Li, Chun-Bo Li, Zhantao Li, Xinle Li, Wuguo Li, Bing-Hui Li, Honggang Li, Jingyong Li, Shikang Li, Shi-Ying Li, Ming Xing Li, Ming-Xing Li, Marilyn Li, Bei-Bei Li, Hong-Lian Li, Shishi Li, Haitong Li, Yuli Li, Ruibing Li, Qingfang Li, Qibing Li, Wende Li, Heng Li, Xiao-Na Li, Xidan Li, Yixing Li, Chengcheng Li, Yu-Jin Li, Baoting Li, Ka Wan Li, Huiyou Li, Binbin Li, Xinyao Li, Gui-xing Li, Niu Li, Shunle Li, Siyue Li, Diyan Li, Mengyao Li, Yixuan Li, Shan-Shan Li, Zhuanjian Li, Gerard Li, Yuyun Li, Zhiqiong Li, Zonglin Li, Pik Yi Li, Jingxin Li, Defeng Li, Zu-guo Li, Xin-Zhu Li, Jia-Xin Li, Kuiliang Li, Pindong Li, Hualian Li, Junhong Li, Youchen Li, W Y Li, Yi-Heng Li, Runbing Li, Yanmin Li, Jingyi Li, Yuxiang Li, Hao-Fei Li, Yining Li, Xiurong Li, Haiyu Li, Huijuan Li, Yunze Li, Xu-Zhao Li, Yanzhong Li, Kainan Li, Guohui Li, Xiaoyan Li, Xu-Bo Li, Yue-Chun Li, Jiahui Li, Huiping Li, Kangyuan Li, Biao Li, Xiaoxuan Li, Anyao Li, Qing-Chang Li, Hongliang Li, Dalei Li, Zongjun Li, Changqing Li, Hanting Li, Dong-Jie Li, Xiaomin Li, Dengxiong Li, Yi-Shuan J Li, Tinghao Li, Zhouxiang Li, Yun-tian Li, Jianliang Li, Guangzhao Li, Yixi Li, Shuyu Dan Li, S A Li, Jinjie Li, Liming Li, Wenqun Li, Guixia Li, Yinan Li, Aoxi Li, Yuanjing Li, Linqi Li, Xixi Li, Bingjue Li, Binghu Li, Yu-Hang Li, Shuhui Li, Mengying Li, Yihong Li, Yaxian Li, Dali Li, Zhiming Li, Xuemei Li, Xueting Li, Yongting Li, Hongxia Li, Zhenjun Li, Danyang Li, Tiandong Li, Di-Jie Li, Bo Li, Jinliang Li, Qiji Li, Zhipeng Li, Xiaoping Li, Linhong Li, Taoyingnan Li, Lieyou Li, Huabin Li, Mao Li, Yongchao Li, Xiaoting Li, Ruotai Li, Yaojia Li, Xiao-Yao Li, Shangming Li, Yaqi Li, Yibo Li, Gui-Hua Li, Zhihong Li, Yandong Li, Chaowei Li, Huiyuan Li, Yuchun Li, Boya Li, Lamei Li, O Li, Joyce Li, Suheng Li, Hui-Ping Li, Junru Li, Zhiqiang Li, Jiangchao Li, Hecheng Li, Yueping Li, Changkai Li, Zhenglong Li, Yajuan Li, Chaoqian Li, Yu-Cheng Li, Yirun Li, Haomiao Li, Qianqian Li, YiQing Li, Zhengliang Li, Weijie Li, Wei-Qin Li, Zongyi Li, Qingxian Li, Dan-Dan Li, Yeshan Li, Zirui Li, Keke Li, Yongpeng Li, Chanyuan Li, Jianbin Li, Shiying Li, Zhongzhe Li, Yumei Li, Xiang-Ping Li, Wenqiang Li, Pei-Shan Li, Zaibo Li, Guangming Li, Xiaoqiang Li, Hanxiao Li, Jiansheng Li, Shuying Li, Xiaomei Li, Pengjie Li, Jiajia Li, Jingwen Li
articles
Zhehan Yang, Junpan Chen, Minghao Wen +6 more · 2024 · Frontiers in endocrinology · Frontiers · added 2026-04-24
Aberrant lipid metabolism is intricately linked to the development of endometrial cancer, and statin lipid-lowering medications are regarded as promising adjunctive therapies for future management of Show more
Aberrant lipid metabolism is intricately linked to the development of endometrial cancer, and statin lipid-lowering medications are regarded as promising adjunctive therapies for future management of this malignancy. This study employed Mendelian randomization (MR) to explore the causal association between lipid traits and endometrial cancer while assessing the potential impact of drug targets on lower lipids on endometrial cancer. Two-sample Mendelian randomization was employed to probe the causal association between lipid traits and endometrial carcinoma. Drug-target Mendelian randomization was also utilized to identify potential drug-target genes for managing endometrial carcinoma. In instances where lipid-mediated effects through particular drug targets were notable, the impacts of these drug targets on endometrial carcinoma risk factors were investigated to bolster the findings. No causal association between genetically predicted lipid traits (LDL-C, TG, TC, and HDL-C) and EC was found in two-sample Mendelian randomization. In drug target Mendelian randomization, genetic modeling of apolipoprotein B (APOB) (OR [95%CI]=0.31, [0.16-0.60]; The results of our MR study revealed no causal association between genetically predicted lipid traits (LDL-C, TG, TC, and HDL-C) and EC. Among the six lipid-lowering drug targets, we observed a significant association between lower predicted APOB levels and higher CETP levels with an increased risk of endometrioid carcinoma. These findings provide novel insights into the importance of lipid regulation in individuals with endometrial carcinoma, warranting further clinical validation and mechanistic investigations. Show less
📄 PDF DOI: 10.3389/fendo.2024.1446457
APOB
Yue Lv, Chengrui Zhao, Qiuyan Jiang +7 more · 2024 · Molecular biology reports · Springer · added 2026-04-24
Obesity is associated with a wide variety of metabolic disorders that impose significant burdens on patients and society. The "browning" phenomenon in white adipose tissue (WAT) has emerged as a promi Show more
Obesity is associated with a wide variety of metabolic disorders that impose significant burdens on patients and society. The "browning" phenomenon in white adipose tissue (WAT) has emerged as a promising therapeutic strategy to combat metabolic disturbances. However, though the anti-diabetic drug dapagliflozin (DAPA) is thought to promote "browning," the specific mechanism of this was previously unclear. In this study, C57BL/6 J male mice were used to establish an obesity model by high-fat diet feeding, and 3T3-L1 cells were used to induce mature adipocytes and to explore the role and mechanism of DAPA in "browning" through a combination of in vitro and in vivo experiments. The results show that DAPA promotes WAT "browning" and improves metabolic disorders. Furthermore, we discovered that DAPA activated "browning" through the fibroblast growth factor receptors 1-liver kinase B1-adenosine monophosphate-activated protein kinase signaling pathway. These findings provide a rational basis for the use of DAPA in treating obesity by promoting the browning of white adipose tissue. Show less
📄 PDF DOI: 10.1007/s11033-024-09540-3
FGFR1
Yue Zhang, Yeru Tan, Jingping Yuan +9 more · 2024 · Cancer letters · Elsevier · added 2026-04-24
Cancer metastasis is the major cause of death in patients with breast cancer (BC). The liver is a common site of breast cancer metastasis, and the 5-year survival rate of patients with breast cancer l Show more
Cancer metastasis is the major cause of death in patients with breast cancer (BC). The liver is a common site of breast cancer metastasis, and the 5-year survival rate of patients with breast cancer liver metastases (BCLMs) is only about 8.5 %. CircRNAs are involved in a variety of cancer-related pathological behaviors, and their unique structure and resistance to RNA degradation enable them to serve as ideal diagnostic biomarkers and therapeutic targets. Therefore, it is important to investigate the role and molecular mechanism of circRNAs in cancer metastasis. CircLIFR-007 was identified as a critical circular RNA in BC metastasis by circRNAs microarray and qRT-PCR experiment. Cell function assays were performed to explore the effect of circLIFR-007 in breast cancer cells. Experiments in vivo validated the function of circLIFR-007. Several molecular assays were performed to investigate the underlying mechanisms. We found that circLIFR-007 acted as a negative controller in breast cancer liver metastasis. CircLIFR-007 upregulates the phosphorylation level of YAP by exporting hnRNPA1 to promote the combination between hnRNPA1 and YAP in the cytoplasm. Overexpression of circLIFR-007 suppressed the expression of liver metastasis-related proteins, SREBF1 and SNAI1, which were regulated by transcription factor YAP. Functionally, circLIFR-007 inhibits the proliferation and metastasis of breast cancer cells both in vivo and in vitro. Show less
no PDF DOI: 10.1016/j.canlet.2024.216907
SNAI1
Chengniu Wang, Xiaorong Wang, Wenran Wang +14 more · 2024 · Cell & bioscience · BioMed Central · added 2026-04-24
The cell development atlas of transition stage from late Carnegie to fetal development (7-9 weeks) remain unclear. It can be seen that the early period of human embryos (7-9 weeks) is a critical resea Show more
The cell development atlas of transition stage from late Carnegie to fetal development (7-9 weeks) remain unclear. It can be seen that the early period of human embryos (7-9 weeks) is a critical research gap. Therefore, we employed single‑cell RNA sequencing to identify cell types and elucidate differentiation relationships. The single‑cell RNA sequencing analysis determines eighteen cell clusters in human embryos during the 7-9 weeks period. We uncover two distinct pathways of cellular development and differentiation. Initially, mesenchymal progenitor cells differentiated into osteoblast progenitor cells and neural stem cells, respectively. Neural stem cells further differentiated into neurons. Alternatively, multipotential stem cells differentiated into adipocyte, hematopoietic stem cells and neutrophil, respectively. Additionally, COL1A2-(ITGA1 + ITGB1) mediated the cell communication between mesenchymal progenitor cells and osteoblast progenitor cells. NCAM1-FGFR1 facilitated the cell communication between mesenchymal progenitor cells and neural stem cells. Notably, NCAM1-NCAM1 as a major contributor mediated the cell communication between neural stem cells and neurons. Moreover, CGA-FSHR simultaneously mediated the communication between multipotential stem cells, adipocyte, hematopoietic stem cells and neutrophil. Distinct cell clusters activated specific transcription factors such as HIC1, LMX1B, TWIST1, and et al., which were responsible for their specific functions. These coregulators, such as HOXB13, VSX2, PAX5, and et al., may mediate cell development and differentiation in human embryos. We provide the cell development atlas for human embryos (7-9 weeks). Two distinct cell development and differentiation pathways are revealed. Show less
📄 PDF DOI: 10.1186/s13578-024-01302-9
FGFR1
Junhong Zhao, Lei Zhang, Yonghong Zhang +10 more · 2024 · International journal of biological sciences · added 2026-04-24
📄 PDF DOI: 10.7150/ijbs.97422
FGFR1
Lingang Dai, Dongwei An, Jiajin Huang +7 more · 2024 · International journal of biological macromolecules · Elsevier · added 2026-04-24
The kidding traits of goats are an important index of production. However, the molecular regulatory mechanisms of kidding traits in goats have not been fully elucidated. This study aimed to investigat Show more
The kidding traits of goats are an important index of production. However, the molecular regulatory mechanisms of kidding traits in goats have not been fully elucidated. This study aimed to investigate the molecular regulatory network of kidding traits in goats. Multi-omics revealed the enrichment of 10 signaling pathways, with fatty acid biosynthesis, biosynthesis of unsaturated fatty acids, and steroid hormone biosynthesis pathways being closely related to reproduction. Interestingly, the key rate-limiting enzymes, fatty acid synthase (FASN), stearoyl-CoA desaturase 5 (SCD5), fatty acid desaturase 1 (FADS1), 3β-hydroxysteroid dehydrogenase/isomerase (3BHSD), and steroidogenic acute regulatory protein (STAR) enriched in these pathways regulate changes in reproduction-related metabolites. In interference experiments, it was observed that suppressing these key rate-limiting enzymes inhibited the expression of CYP19A1, ESR2, and FSHR. Furthermore, interference inhibited granulosa cell proliferation, caused cell cycle arrest, and promoted apoptosis. Thus, these results suggest that the specific markers of nanny goats with multiple kids are the key rate-limiting enzymes FASN, SCD5, FADS1, 3BHSD, and STAR. These findings may greatly enhance the understanding of regulatory mechanisms that govern goat parturition. Show less
no PDF DOI: 10.1016/j.ijbiomac.2024.136737
FADS1
Miao Wang, Kangting Luo, Tongtong Sha +7 more · 2024 · Nutrients · MDPI · added 2026-04-24
Excessive fluoride exposure induces skeletal fluorosis, but the specific mechanism responsible is still unclear. Therefore, this study aimed to identify the pathogenesis of fluoride-induced bone injur Show more
Excessive fluoride exposure induces skeletal fluorosis, but the specific mechanism responsible is still unclear. Therefore, this study aimed to identify the pathogenesis of fluoride-induced bone injuries. We systematically searched fluoride-induced bone injury-related genes from five databases. Then, these genes were subjected to enrichment analyses. A TF (transcription factor)-mRNA-miRNA network and protein-protein interaction (PPI) network were constructed using Cytoscape, and the Human Protein Atlas (HPA) database was used to screen the expression of key proteins. The candidate pharmacological targets were predicted using the Drug Signature Database. A total of 85 studies were included in this study, and 112 osteoblast-, 35 osteoclast-, and 41 chondrocyte-related differential expression genes (DEGs) were identified. Functional enrichment analyses showed that the Atf4, Bcl2, Col1a1, Fgf21, Fgfr1 and Il6 genes were significantly enriched in the PI3K-Akt signaling pathway of osteoblasts, Mmp9 and Mmp13 genes were enriched in the IL-17 signaling pathway of osteoclasts, and Bmp2 and Bmp7 genes were enriched in the TGF-beta signaling pathway of chondrocytes. With the use of the TF-mRNA-miRNA network, the Col1a1, Bcl2, Fgfr1, Mmp9, Mmp13, Bmp2, and Bmp7 genes were identified as the key regulatory factors. Selenium methyl cysteine, CGS-27023A, and calcium phosphate were predicted to be the potential drugs for skeletal fluorosis. These results suggested that the PI3K-Akt signaling pathway being involved in the apoptosis of osteoblasts, with the IL-17 and the TGF-beta signaling pathways being involved in the inflammation of osteoclasts and chondrocytes in fluoride-induced bone injuries. Show less
📄 PDF DOI: 10.3390/nu16152500
FGFR1
Jiayi Li, Zheng Wang, Yuwei Zhang +7 more · 2024 · Environmental research · Elsevier · added 2026-04-24
Short-chain chlorinated paraffins (SCCPs), a class of persistent organic pollutants, have been found to cause diverse organ and systemic toxicity. However, little is known about their neurotoxic effec Show more
Short-chain chlorinated paraffins (SCCPs), a class of persistent organic pollutants, have been found to cause diverse organ and systemic toxicity. However, little is known about their neurotoxic effects. In this study, we exposed BV2, a mouse microglia cell line, to environmentally relevant concentration of SCCPs (1 μg/L, 10 μg/L, 100 μg/L) for 24 h to investigate their impacts on the nervous system. Our observations revealed that SCCPs induced the activation of BV2 microglia, as indicated by altered morphology, stimulated cell proliferation, enhanced phagocytic and migratory capabilities. Analysis at the mRNA level confirmed the activation status, with the downregulation of TMEM119 and Tgfbr1, and upregulation of Iba1 and CD11b. The upregulated expression of genes such as cenpe, mki67, Axl, APOE and LPL also validated alterations in cell functions. Moreover, BV2 microglia presented an M2 alternative phenotype upon SCCPs exposure, substantiated by the reduction of NF-κB, TNF-α, IL-1β, and the elevation of TGF-β. Additionally, SCCPs caused lipid metabolic changes in BV2 microglia, characterized by the upregulations of long-chain fatty acids and acylcarnitines, reflecting an enhancement of β-oxidation. This aligns with our findings of increased ATP production upon SCCPs exposure. Intriguingly, cell activation coincided with elevated levels of omega-3 polyunsaturated fatty acids. Furthermore, activated microglial medium remarkably altered the proliferation and differentiation of mouse neural stem cells. Collectively, exposure to environmentally relevant concentrations of SCCPs resulted in activation and lipid metabolic alterations in BV2 microglia, potentially impacting neurogenesis. These findings provide valuable insights for further research on the neurotoxic effect of SCCPs. Show less
no PDF DOI: 10.1016/j.envres.2024.118602
LPL
Yue Li, Peiqi Liu, Yifan Yao +5 more · 2024 · Molecular therapy. Nucleic acids · Elsevier · added 2026-04-24
Anorectal malformations (ARMs) are congenital diseases that lead to postoperative fecal incontinence, constipation, and soiling, despite improvements in surgery; however, their pathological mechanisms Show more
Anorectal malformations (ARMs) are congenital diseases that lead to postoperative fecal incontinence, constipation, and soiling, despite improvements in surgery; however, their pathological mechanisms remain unclear. Here, we report the role of microRNA-141-3p in maintaining homeostasis between apoptosis and autophagy in the lumbosacral defecation center of fetal rats with ARMs. Elevated microRNA-141-3p expression inhibited YIN-YANG-1 expression by binding its 3' UTR, and repressed autophagy and triggered apoptosis simultaneously. Then, adenylate cyclase 3 was screened to be the downstream target gene of YIN-YANG-1 by chromatin immunoprecipitation sequencing experiments, and Yin Yang 1 could positively activate the transcription of adenylate cyclase 3 by directly interacting with the motif GAGATGG and ATGG in its promoter. Intraamniotic microinjection of adeno-rno-microRNA-141-3p-sponge-GFP in fetal rats with ARMs on embryonic day 15 restored apoptosis-autophagy homeostasis. These findings reveal that microRNA-141-3p upregulation impaired homeostasis between apoptosis and autophagy by inhibiting the YIN-YANG-1/adenylate cyclase 3 axis, and that intraamniotic injection of anti-microRNA-141-3p helped maintain homeostasis in the lumbosacral defecation center of ARMs during embryogenesis. Show less
📄 PDF DOI: 10.1016/j.omtn.2024.102163
ADCY3
Caiyun Jiang, Yuanhang Shi, Xuefeng Shi +6 more · 2024 · Poultry science · Elsevier · added 2026-04-24
There was no significant difference in the composition and content of fatty acids in eggs among different breeds initially, but following the supplementation of flaxseed oil, Dwarf Layer were observed Show more
There was no significant difference in the composition and content of fatty acids in eggs among different breeds initially, but following the supplementation of flaxseed oil, Dwarf Layer were observed to deposit more n-3 polyunsaturated fatty acid (PUFA) in eggs. Currently, there is limited research on the mechanisms underlying the differences in egg composition among different breeds. Therefore, in this study, 150 twenty-four-wk-old hens of each breed, including the Dwarf Layer and White Leghorn, were fed either a basal diet or a diet supplemented with 2.5% flaxseed oil. After 28 d, eggs and liver samples were collected to determine fatty acid composition, and serum, liver, intestine, and follicles were collected for subsequent biochemical, intestinal morphology, and lipid metabolism-related genes expression analysis. Duodenal contents were collected for microbial analysis. The results showed that there was no significant difference in the content and deposition efficiency of total n-3 PUFA in the liver of the 2 breeds, but the content and deposition efficiency of total n-3 PUFA in the egg of Dwarf Layer were significantly higher than those of White Leghorn after feeding flaxseed oil. Flaxseed oil and breeds did not have significant effects on cholesterol (CHO), free fatty acids (NEFA), low-density lipoprotein (LDL), and estrogen (E Show less
📄 PDF DOI: 10.1016/j.psj.2024.104016
FADS1
Melanie Modder, Wietse In Het Panhuis, Mohan Li +11 more · 2024 · Cardiovascular research · Oxford University Press · added 2026-04-24
Angiopoietin-like 3 (ANGPTL3) and 4 (ANGPTL4) inhibit lipoprotein lipase to regulate tissue fatty acid (FA) uptake from triglyceride (TG)-rich lipoproteins such as very low density lipoproteins (VLDL) Show more
Angiopoietin-like 3 (ANGPTL3) and 4 (ANGPTL4) inhibit lipoprotein lipase to regulate tissue fatty acid (FA) uptake from triglyceride (TG)-rich lipoproteins such as very low density lipoproteins (VLDL). While pharmacological inhibition of ANGPTL3 is being evaluated as a lipid-lowering strategy, systemic ANGPTL4 inhibition is not pursued due to adverse effects. This study aims to compare the therapeutic potential of liver-specific Angptl3 and Angptl4 silencing to attenuate hyperlipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice, a well-established humanized model for lipoprotein metabolism. Mice were subcutaneously injected twice per week with saline or liver-targeted antisense oligonucleotides against Angptl3, Angptl4, both, or a scrambled oligonucleotide. Plasma lipid levels, VLDL clearance, and hepatic VLDL production were determined, and atherosclerosis development was assessed. For toxicological evaluation, cynomolgus monkeys were treated with three dosages of liver-targeted ANGPTL4-silencing oligonucleotides. Liver-targeted Angptl4 silencing reduced plasma TGs (-48%) and total cholesterol (-56%), explained by higher VLDL-derived FA uptake by brown adipose tissue and lower VLDL production by the liver. Accordingly, Angptl4 silencing reduced atherosclerotic lesion size (-86%) and improved lesion stability. Hepatic Angptl3 silencing similarly attenuated hyperlipidemia and atherosclerosis development. While Angptl3 and Angptl4 silencing lowered plasma TGs in the refed and fasted state, respectively, combined Angptl3/4 silencing lowered plasma TGs independent of the nutritional state. In cynomolgus monkeys, anti-ANGPTL4 ASO treatment was well tolerated without adverse effects. Liver-targeted Angptl4 silencing potently attenuates hyperlipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice, and liver-targeted ANGPTL4 silencing is well tolerated in non-human primates. These data warrant further clinical development of liver-targeted ANGPTL4 silencing. Show less
📄 PDF DOI: 10.1093/cvr/cvae195
ANGPTL4
Jun Yi Liu, Yan Zhi Yi, Qi Wei Guo +10 more · 2024 · Lipids in health and disease · BioMed Central · added 2026-04-24
Diabetes mellitus is generally accompanied by dyslipidaemia, but inconsistent relationships between lipid profiles and diabetes are noted. Moreover, genetic variations in insertion/deletion (I/D) poly Show more
Diabetes mellitus is generally accompanied by dyslipidaemia, but inconsistent relationships between lipid profiles and diabetes are noted. Moreover, genetic variations in insertion/deletion (I/D) polymorphisms at angiotensin-converting enzyme gene (ACE) and T/C polymorphisms in the angiotensin type 1 receptor gene (AGTR1) are related to diabetes and lipid levels, but the associations are controversial. Thus, the current research aimed to explore the effects of ACE I/D, AGTR1 rs5182 and diabetes mellitus on serum lipid profiles in 385 Chinese participants with an average age of 75.01 years. The ACE I/D variant was identified using the polymerase chain reaction (PCR) method, whereas the AGTR1 rs5182 polymorphism was identified using the PCR-based restriction fragment length polymorphism (PCR-RFLP) method and verified with DNA sequencing. Total cholesterol (TC), triglyceride (TG), apolipoprotein A (ApoA), apolipoprotein B (ApoB), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels were measured using routine methods, and the lipid ratios were calculated. ACE I/D, but not AGTR1 rs5182, was a predictor of TG/HDL-C for the whole study population. Both ACE I/D and AGTR1 rs5182 were predictors of HDL-C and LDL-C levels in females but not in males. Moreover, in females, diabetes mellitus and ACE I/D were identified as predictors of TG and TG/HDL-C, whereas AGTR1 rs5182 and diabetes mellitus were predictors of TG/HDL-C. Moreover, diabetes mellitus and the combination of ACE I/D and AGTR1 rs5182 variations were predictors of TG and TG/HDL-C exclusively in females. The results demonstrated the potential for gender-dependent interactions of ACE I/D, AGTR1 rs5182, and diabetes on lipid profiles. These findings may serve as an additional explanation for the inconsistent changes of blood lipids in individuals with diabetes mellitus, thereby offering a novel perspective for the clinical management of blood lipid levels in diabetic patients. Show less
📄 PDF DOI: 10.1186/s12944-024-02222-w
APOB
Chunhui Nian, Xin Gan, Qunpeng Liu +10 more · 2024 · Current medicinal chemistry · Bentham Science · added 2026-04-24
Bis-chalcone compounds with symmetrical structures, either isolated from natural products or chemically synthesized, have multiple pharmacological activities. Asymmetric Bis-chalcone compounds have no Show more
Bis-chalcone compounds with symmetrical structures, either isolated from natural products or chemically synthesized, have multiple pharmacological activities. Asymmetric Bis-chalcone compounds have not been reported before, which might be attributed to the synthetic challenges involved, and it remains unknown whether these compounds possess any potential pharmacological activities. The aim of this study is to investigate the synthesis route of asymmetric bis-chalcone compounds and identify potential candidates with efficient anti-tumor activity. The two-step structural optimization of the bis-chalcone compounds was carried out sequentially, guided by the screening of the compounds for their growth inhibitory activity against gastric cancer cells by MTT assay. The QSAR model of compounds was established through random forest (RF) algorithm. The activities of the optimal compound J3 on growth inhibition, apoptosis, and apoptosis-inducing protein expression in gastric cancer cells were investigated sequentially by colony formation assay, flow cytometry, and western blotting. Further, the inhibitory effects of J3 on the FGFR1 signaling pathway were explored by Western Blotting, shRNA, and MTT assays. Finally, the 27 asymmetric bis-chalcone compounds, including two types (N and J) were sequentially designed and synthesized. Some N-class compounds have good inhibitory activity on the growth of gastric cancer cells. The vast majority of J-class compounds optimized on the basis of N3 exhibit excellent inhibitory activity on gastric cancer cell growth. We established a QSAR model (R In summary, this study outlines a viable method for the synthesis of novel asymmetric bischalcone compounds. Furthermore, the compound J3 demonstrates substantial promise as a potential candidate for an anti-tumor drug. Show less
no PDF DOI: 10.2174/0109298673298420240530093525
FGFR1
Enmin Ding, Fuchang Deng, Jianlong Fang +23 more · 2024 · Environmental health perspectives · added 2026-04-24
Environmental contaminants (ECs) are increasingly recognized as crucial drivers of dyslipidemia and cardiovascular disease (CVD), but the comprehensive impact spectrum and interlinking mechanisms rema Show more
Environmental contaminants (ECs) are increasingly recognized as crucial drivers of dyslipidemia and cardiovascular disease (CVD), but the comprehensive impact spectrum and interlinking mechanisms remain uncertain. We aimed to systematically evaluate the association between exposure to 80 ECs across seven divergent categories and markers of dyslipidemia and investigate their underpinning biomolecular mechanisms via an unbiased integrative approach of internal chemical exposome and multi-omics. A longitudinal study involving 76 healthy older adults was conducted in Jinan, China, and participants were followed five times from 10 September 2018 to 19 January 2019 in 1-month intervals. A broad spectrum of seven chemical categories covering the prototypes and metabolites of 102 ECs in serum or urine as well as six serum dyslipidemia markers [total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein (Apo)A1, ApoB, and ApoE4] were measured. Multi-omics, including the blood transcriptome, serum/urine metabolome, and serum lipidome, were profiled concurrently. Exposome-wide association study and the deletion/substitution/addition algorithms were applied to explore the associations between 80 EC exposures detection frequency Eight main ECs [1-naphthalene, 1-pyrene, 2-fluorene, dibutyl phosphate, tri-phenyl phosphate, mono-(2-ethyl-5-hydroxyhexyl) phthalate, chromium, and vanadium] were significantly associated with most dyslipidemia markers. Multi-omics indicated that the associations were mediated by endogenous biomolecules and pathways, primarily pertinent to CVD, inflammation, and metabolism. Clinical measures of cytokines and electrocardiograms further cross-validated the association of these exogenous ECs with systemic inflammation and cardiac function, demonstrating their potential mechanisms in driving dyslipidemia pathogenesis. It is imperative to prioritize mitigating exposure to these ECs in the primary prevention and control of the dyslipidemia epidemic. https://doi.org/10.1289/EHP13864. Show less
📄 PDF DOI: 10.1289/EHP13864
APOB
Guang Wang, Pei Li, Si-Wei Su +4 more · 2024 · Aging · Impact Journals · added 2026-04-24
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition with painful bladder. At present, the pathogenesis of IC/BPS is still unknown. Quercetin (QCT) is a kind of natural flavonoi Show more
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition with painful bladder. At present, the pathogenesis of IC/BPS is still unknown. Quercetin (QCT) is a kind of natural flavonoid with wide sources and multiple biological activities. The purpose of this study was to explore the effects of QCT on mRNA expression and related regulatory signal pathways in IC model rats. LL-37 was used to induce the IC/BPS model rats. 20 mg/kg QCT was injected intraperitoneally into IC/BPS rats. ELISA, HE, Masson and TB staining were used to evaluate the level of inflammation and pathology. The concentration of QCT in rats was detected by HPLC. The mRNA sequencing was used to detect the differentially expressed (DE) mRNA in each group. The over-expression experiment of Lpl was carried out in IC/BPS model rats. QCT treatment significantly decreased the level of MPO, IL-1β, IL-6 and TNF-α induced by LL-37 in rats, and alleviated bladder injury and mast cell degranulation. There were significant differences in mRNA sequencing data between groups, and the hub gene Lpl were screened by Cytohubba. The expression of Lpl was downregulated in IC/BPS rats. QCT intervention promoted Lpl expression. Overexpression of Lpl reduced the bladder injury induced by LL-37, increased GAG level and decreased the expression of MPO, IL-1β, IL-6 and TNF-α. In this study, we provided the DE mRNA in IC/BPS rats treated with QCT, the signaling pathways for DE enrichment, screened out the hub genes, and revealed that Lpl overexpression alleviated IC/BPS model rats. Show less
📄 PDF DOI: 10.18632/aging.205682
LPL
Haoran Li, Jianjun Zhu, Xinglei Liu +9 more · 2024 · Glia · Wiley · added 2026-04-24
Tumor-associated astrocytes (TAAs) in the glioblastoma microenvironment play an important role in tumor development and malignant progression initiated by glioma stem cells (GSCs). In the current stud Show more
Tumor-associated astrocytes (TAAs) in the glioblastoma microenvironment play an important role in tumor development and malignant progression initiated by glioma stem cells (GSCs). In the current study, normal human astrocytes (NHAs) were cultured and continuously treated with GSC-derived exosomes (GSC-EXOs) induction to explore the mechanism by which GSCs affect astrocyte remodeling. This study revealed that GSC-EXOs can induce the transformation of NHAs into TAAs, with relatively swollen cell bodies and multiple extended processes. In addition, high proliferation, elevated resistance to temozolomide (TMZ), and increased expression of TAA-related markers (TGF-β, CD44, and tenascin-C) were observed in the TAAs. Furthermore, GSC-derived exosomal miR-3065-5p could be delivered to NHAs, and miR-3065-5p levels increased significantly in TAAs, as verified by miRNA expression profile sequencing and Reverse transcription polymerase chain reaction. Overexpression of miR-3065-5p also enhanced NHA proliferation, elevated resistance to TMZ, and increased the expression levels of TAA-related markers. In addition, both GSC-EXO-induced and miR-3065-5p-overexpressing NHAs promoted tumorigenesis of GSCs in vivo. Discs Large Homolog 2 (DLG2, downregulated in glioblastoma) is a direct downstream target of miR-3065-5p in TAAs, and DLG2 overexpression could partially reverse the transformation of NHAs into TAAs. Collectively, these data demonstrate that GSC-EXOs induce the transformation of NHAs into TAAs via the miR-3065-5p/DLG2 signaling axis and that TAAs can further promote the tumorigenesis of GSCs. Thus, precisely blocking the interactions between astrocytes and GSCs via exosomes may be a novel strategy to inhibit glioblastoma development, but more in-depth mechanistic studies are still needed. Show less
no PDF DOI: 10.1002/glia.24506
DLG2
Hairong Yao, Dantong Liu, Fangyuan Gao +2 more · 2024 · Archives of medical science : AMS · added 2026-04-24
Ovarian cancer (OC) is the malignant tumor with the highest mortality among gynecological cancers. Chemotherapy resistance is a major obstacle to OC therapy. Circular RNAs (circRNAs) play crucial role Show more
Ovarian cancer (OC) is the malignant tumor with the highest mortality among gynecological cancers. Chemotherapy resistance is a major obstacle to OC therapy. Circular RNAs (circRNAs) play crucial roles in cancer development and chemoresistance. However, the role and potential mechanism of has-circ-001567 (circ-VPS13C) in chemoresistance of OC remain unknown. The levels of circ-VPS13C, miR-106b-5p and 14-3-3 zeta (YWHAZ) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) or western blot assay. Cell Counting Kit-8 (CCK-8) assay was used to assess cell viability and calculate the half inhibition concentration (IC Circ-VPS13C and YWHAZ were up-regulated, while miR-106b-5p was down-regulated in DDP-resistant OC tissues and cells. Knockdown of circ-VPS13C enhanced DDP sensitivity by repressing autophagy in DDP-resistant cells. Circ-VPS13C increased DDP resistance via sponging miR-106b-5p. Moreover, miR-106b-5p directly targeted YWHAZ. Up-regulation of YWHAZ alleviated the decrease in DDP resistance caused by circ-VPS13C depletion. In addition, circ-VPS13C silencing decreased DDP resistance Circ-VPS13C knockdown enhanced DDP sensitivity of OC through modulation of autophagy via the miR-106b-5p/YWHAZ axis, providing a new biomarker for improving the efficacy of OC chemotherapy. Show less
no PDF DOI: 10.5114/aoms/133038
VPS13C
Xiaoting Xi, Xiaolei Liu, Qianbo Chen +5 more · 2024 · PloS one · PLOS · added 2026-04-24
Diabetic retinopathy (DR) is a severe microangiopathy of diabetes. Müller cells play an important role in the development of DR. Acteoside (ACT) has been reported to be effective in the treatment of D Show more
Diabetic retinopathy (DR) is a severe microangiopathy of diabetes. Müller cells play an important role in the development of DR. Acteoside (ACT) has been reported to be effective in the treatment of DR. In this study, we explored the molecular mechanism of ACT in the treatment of DR from the perspective of the reactive proliferation of Müller cells. The effect of ACT on DR was investigated via high-glucose (HG) treatment of Müller RMC-1 cells and an injection of streptozotocin (STZ) in constructed DR cells and animal models. The results showed that after ACT treatment, damage to the retinal structure in DR rats was alleviated, the number of hemangiomas was reduced, and the penetration of blood vessels was weakened. In addition, ACT treatment improved the hypertrophy and gliogenesis of Müller cells during DR, promoted the expression of Kir4.1 and activated the PI3K/Akt signaling pathway. ACT treatment inhibited the proliferation and migration of RMC-1 cells and promoted the expression of Kir4.1. TXNIP overexpression effectively reversed the inhibitory effect of ACT on the proliferation and migration of Müller cells and its induction of Kir4.1 expression. In addition, TXNIP knockdown effectively reversed the inhibitory effect of HG on the expression of p-PI3K and p-Akt, whereas TXNIP overexpression had the opposite effect, and treatment with the PI3K/AKT pathway inhibitor LY294002 effectively reversed the effect of TXNIP knockdown. Animal experiments also confirmed that the therapeutic effect of ACT on DR rats could be reversed by the overexpression of TXNIP or LY294002. In conclusion, ACT inhibits Müller cell reactive proliferation and alleviates diabetic retinopathy by regulating TXNIP and mediating the expression of Kir4.1 channels in a PI3K/Akt-dependent manner. Show less
no PDF DOI: 10.1371/journal.pone.0312565
RMC1
Ying Kong, Xinyue Zhao, Zhaofu Wang +14 more · 2024 · Molecular cancer therapeutics · added 2026-04-24
The aberrant activation of FGFR acts as a potent driver of multiple types of human cancers. Despite the development of several conventional small-molecular FGFR inhibitors, their clinical efficacy is Show more
The aberrant activation of FGFR acts as a potent driver of multiple types of human cancers. Despite the development of several conventional small-molecular FGFR inhibitors, their clinical efficacy is largely compromised because of low selectivity and side effects. In this study, we report the selective FGFR1/2-targeting proteolysis-targeting chimera BR-cpd7 that displays significant isoform specificity to FGFR1/2 with half maximal degradation concentration values around 10 nmol/L while sparing FGFR3. The following mechanistic investigation reveals the reduced FGFR signaling, through which BR-cpd7 induces cell-cycle arrest and consequently blocks the proliferation of multiple FGFR1/2-dependent tumor cells. Importantly, BR-cpd7 has almost no antiproliferative activity against cancer cells without FGFR aberrations, furtherly supporting its selectivity. In vivo, BR-cpd7 exhibits robust antitumor effects in FGFR1-dependent lung cancer at well-tolerated dose schedules, accompanied by complete FGFR1 depletion. Overall, we identify BR-cpd7 as a promising candidate for developing a selective FGFR1/2-targeted agent, thereby offering a new therapeutic strategy for human cancers in which FGFR1/2 plays a critical role. Show less
no PDF DOI: 10.1158/1535-7163.MCT-23-0719
FGFR1
Zhonglin Li, Jinfang Zhao, Ya Wu +9 more · 2024 · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · added 2026-04-24
According to recent research, metabolic-associated fatty liver disease (MAFLD) has emerged as an important underlying etiology of hepatocellular carcinoma (HCC). However, the molecular mechanism of MA Show more
According to recent research, metabolic-associated fatty liver disease (MAFLD) has emerged as an important underlying etiology of hepatocellular carcinoma (HCC). However, the molecular mechanism of MAFLD-HCC is still unclear. Tumor necrosis factor receptor-associated factor 2 (TRAF2) is the key molecule to mediate the signal of inflammatory NF-κB pathway. This study aims to investigate the potential dysregulation of TRAF2 and its biological function in MAFLD-HCC. Huh7 TRAF2 Show less
no PDF DOI: 10.1096/fj.202302307R
AXIN1
Linqing Pan, Fuquan Zhu, Aochen Yu +8 more · 2024 · Gene · Elsevier · added 2026-04-24
The trophoblast epithelial-to-mesenchymal transition (EMT) is a procedure related to embryo implantation, spiral artery establishment and fetal-maternal communication, which is a key event for success Show more
The trophoblast epithelial-to-mesenchymal transition (EMT) is a procedure related to embryo implantation, spiral artery establishment and fetal-maternal communication, which is a key event for successful pregnancy. Inadequate EMT is one of the pathological mechanisms of recurrent miscarriage (RM). Whole-exome sequencing revealed that the mutation of bromodomain PHD-finger transcription factor (BPTF) was strongly associated with RM. In the present study, the effects of BPTF on EMT and the underlying mechanism were investigated. We found that the expression of BPTF in the villi of RM patients was significantly downregulated. Gene Ontology (GO) analysis revealed that BPTF participated in cell adhesion. The knockdown of BPTF prevented EMT and attenuated trophoblast invasion in vitro. BPTF activated Slug transcription by binding directly to the promoter region of the Slug gene. Interestingly, the protein levels of both Slug and BPTF were decreased in the villous cytotrophoblasts (VCTs) of RM villi. In conclusion, BPTF participates in the regulation of trophoblast EMT by activating Slug expression, suggesting that BPTF defects are an important factor in RM pathogenesis. Show less
no PDF DOI: 10.1016/j.gene.2024.148405
SNAI1
Yingying Chen, Hui Liu, Chaomeng Wang +6 more · 2024 · British journal of haematology · Blackwell Publishing · added 2026-04-24
Paroxysmal nocturnal haemoglobinuria (PNH) is a disorder resulting from erythrocyte membrane deficiencies caused by PIG-A gene mutations. While current treatments alleviate symptoms, they fail to addr Show more
Paroxysmal nocturnal haemoglobinuria (PNH) is a disorder resulting from erythrocyte membrane deficiencies caused by PIG-A gene mutations. While current treatments alleviate symptoms, they fail to address the underlying cause of the disease-the pathogenic PNH clones. In this study, we found that the expression of carbamoyl phosphate synthetase 1 (CPS1) was downregulated in PNH clones, and the level of CPS1 was negatively correlated with the proportion of PNH clones. Using PIG-A knockout K562 (K562 KO) cells, we demonstrated that CPS1 knockdown increased cell proliferation and altered cell metabolism, suggesting that CPS1 participates in PNH clonal proliferation through metabolic reprogramming. Furthermore, we observed an increase in the expression levels of the histone demethylase JMJD1C in PNH clones, and JMJD1C expression was negatively correlated with CPS1 expression. Knocking down JMJD1C in K562 KO cells upregulated CPS1 and H3K36me3 expression, decreased cell proliferation and increased cell apoptosis. Chromatin immunoprecipitation analysis further demonstrated that H3K36me3 regulated CPS1 expression. Finally, we demonstrated that histone demethylase inhibitor JIB-04 can suppressed K562 KO cell proliferation and reduced the proportion of PNH clones in PNH mice. In conclusion, aberrant regulation of the JMJD1C-H3K36me3-CPS1 axis contributes to PNH clonal proliferation. Targeting JMJD1C with a specific inhibitor unveils a potential strategy for treating PNH patients. Show less
no PDF DOI: 10.1111/bjh.19477
CPS1
Ao He, Zhisheng Hong, Zhaoyi Jing +2 more · 2024 · Archives of dermatological research · Springer · added 2026-04-24
This study leverages the most up-to-date lipidomic data to provide fresh perspectives on the treatment and prevention of atopic dermatitis. The analysis utilized genome-wide association study (GWAS) d Show more
This study leverages the most up-to-date lipidomic data to provide fresh perspectives on the treatment and prevention of atopic dermatitis. The analysis utilized genome-wide association study (GWAS) data on 179 circulating plasma lipids and AD GWAS data. The primary analysis method employed was the inverse variance weighting (IVW) method, and several sensitivity analyses were conducted to ensure the reliability of the results. Additionally, summary-data-based MR (SMR) and colocalization analysis were utilized to investigate the underlying biological pathways of AD. After rigorous analyses, the IVW method utilized in TSMR analysis pinpointed six plasma lipids with potentially reduced AD risk when elevated. Subsequently, MVMR analysis revealed that there is no independent causal effect of different lipids within the same subtype on AD. Bidirectional MR analysis did not indicate reverse causality, and SMR analysis suggested FADS1 and FADS2 as potential drug targets for AD treatment. This MR study demonstrated a causal relationship between specific plasma lipid levels and AD risk at the genetic level, which can be used for clinical screening of AD plasma lipid biomarkers and provides a novel perspective on potential therapeutic strategies. Show less
📄 PDF DOI: 10.1007/s00403-024-03539-3
FADS1
Yuanyuan Li, Chan Xu, Feng Zhao +10 more · 2024 · Human molecular genetics · Oxford University Press · added 2026-04-24
More than 60 monogenic genes mutated in steroid-resistant nephrotic syndrome (SRNS) have been identified. Our previous study found that mutations in nucleoporin 160 kD (NUP160) are implicated in SRNS. Show more
More than 60 monogenic genes mutated in steroid-resistant nephrotic syndrome (SRNS) have been identified. Our previous study found that mutations in nucleoporin 160 kD (NUP160) are implicated in SRNS. The NUP160 gene encodes a component of the nuclear pore complex. Recently, two siblings with homozygous NUP160 mutations presented with SRNS and a nervous system disorder. However, replication of nephrotic syndrome (NS)-associated phenotypes in a mammalian model following loss of Nup160 is needed to prove that NUP160 mutations cause SRNS. Here, we generated a podocyte-specific Nup160 knockout (Nup160podKO) mouse model using CRISPR/Cas9 and Cre/loxP technologies. We investigated NS-associated phenotypes in these Nup160podKO mice. We verified efficient abrogation of Nup160 in Nup160podKO mice at both the DNA and protein levels. We showed that Nup160podKO mice develop typical signs of NS. Nup160podKO mice exhibited progression of proteinuria to average albumin/creatinine ratio (ACR) levels of 15.06 ± 2.71 mg/mg at 26 weeks, and had lower serum albumin levels of 13.13 ± 1.34 g/l at 30 weeks. Littermate control mice had urinary ACR mean values of 0.03 mg/mg and serum albumin values of 22.89 ± 0.34 g/l at the corresponding ages. Further, Nup160podKO mice exhibited glomerulosclerosis compared with littermate control mice. Podocyte-specific Nup160 knockout in mice led to NS and glomerulosclerosis. Thus, our findings strongly support that mutations in NUP160 cause SRNS. The newly generated Nup160podKO mice are a reliable mammalian model for future study of the pathogenesis of NUP160-associated SRNS. Show less
no PDF DOI: 10.1093/hmg/ddad211
NUP160
Hongqin Zhong, Ling Wang, Xue Zhu +5 more · 2024 · Journal of Cancer · added 2026-04-24
Lung squamous cell carcinoma (LUSC), a subset of non-small cell lung cancer (NSCLC), accounts for about 30% of all lung cancers (LC) and exhibits a dismal response to current therapeutic protocols. Ex Show more
Lung squamous cell carcinoma (LUSC), a subset of non-small cell lung cancer (NSCLC), accounts for about 30% of all lung cancers (LC) and exhibits a dismal response to current therapeutic protocols. Existed studies have indicated that aberrations in fibroblast growth factor receptors (FGFRs) play a pivotal role in the progression of LUSC, rendering them as attractive targets for therapeutic intervention in this cancer type. This study found that Erdafitinib (Erda), a novel pan-FGF receptor tyrosine kinase inhibitor (TKI), exerted a cytotoxic effect on LUSC cells. However, STAT3, the downstream target of FGFRs, remained still activated despite Erdafitinib treatment. Then, a STAT3 inhibitor, Stattic (Sta), was concurrently used with Erdafitinib, and the combined treatment demonstrated a synergistic efficacy in both Show less
📄 PDF DOI: 10.7150/jca.97477
FGFR1
Yuyan Zhang, Xinhai Jiang, Weizhi Wang +13 more · 2024 · Arteriosclerosis, thrombosis, and vascular biology · added 2026-04-24
Atherosclerosis is the most common cause of cardiovascular diseases. Clinical studies indicate that loss-of-function ASGR1 (asialoglycoprotein receptor 1) is significantly associated with lower plasma Show more
Atherosclerosis is the most common cause of cardiovascular diseases. Clinical studies indicate that loss-of-function ASGR1 (asialoglycoprotein receptor 1) is significantly associated with lower plasma cholesterol levels and reduces cardiovascular disease risk. However, the effect of ASGR1 on atherosclerosis remains incompletely understood; whether inhibition of ASGR1 causes liver injury remains controversial. Here, we comprehensively investigated the effects and the underlying molecular mechanisms of ASGR1 deficiency and overexpression on atherosclerosis and liver injury in mice. We engineered After being fed a Western diet for 12 weeks, Inhibition of ASGR1 inhibits atherosclerosis in Western diet-fed Show less
📄 PDF DOI: 10.1161/ATVBAHA.124.321076
LPL
Xuan Liu, Yuan-Jing Li, Yue-Jia Li +4 more · 2024 · Zhonghua nan ke xue = National journal of andrology · added 2026-04-24
To explore the potential impact of lipid metabolism-related single nucleotide polymorphisms (SNP) on semen quality in men. We selected 284 semen samples from Xingtai Infertility Hospital and Hebei Hum Show more
To explore the potential impact of lipid metabolism-related single nucleotide polymorphisms (SNP) on semen quality in men. We selected 284 semen samples from Xingtai Infertility Hospital and Hebei Human Sperm Bank collected between February and October 2023, 33 from oligozoospermia (OS), 97 from asthenozoospermia (AS) and 54 from oligoasthenozoospermia (OAS) patients and the other 100 from normal men. We performed computer-assisted semen analysis (CASA) of the samples, extracted blood DNA and, using the MassARRAY System, genotyped the target genes, determined the genotypes of 13 SNPs and compared their distribution, their correlation with BMI and semen quality in different groups. The mutant homozygous (TT) genotype of the FADS2 rs2727270 gene seemed to be a risk factor for AS (OR = 4.420, P= 0.047), while the APOA2 rs5082-A allele and MC4R rs17782313 heterozygous (TC) genotype important protective factors for OS (OR = 0.422 and 0.389; P= 0.045 and 0.043, respectively). A significantly higher sperm concentration was found associated with the MC4R rs17782313 heterozygous (TC) genotype than with the homozygous (CC) genotype. Stratification analysis showed that the protective effect of the TC genotype was decreased with increased BMI and remained with the interaction of the rs5082 and rs17782313 genotypes. FADS2 rs2727270, APOA2 rs5082 and MC4R rs17782313 were significantly correlated with the risk of abnormal semen parameters. Show less
no PDF
MC4R
Shiyuan Wang, Jun Li, Ying Li +7 more · 2024 · Global medical genetics · added 2026-04-24
Cerebral venous sinus thrombosis (CVST) and hyperlipidemia are severe complications of L-Asparaginase (L-Asp) during the treatment of B-cell acute lymphoblastic leukemia (B-ALL). Herein, we reported a Show more
Cerebral venous sinus thrombosis (CVST) and hyperlipidemia are severe complications of L-Asparaginase (L-Asp) during the treatment of B-cell acute lymphoblastic leukemia (B-ALL). Herein, we reported a 9-year-old B-ALL boy who underwent abnormal hypertriglyceridemia and CVST presenting as seizures and disturbance of consciousness twice during the induction therapy. Fortunately, he survived treatment with anticoagulant and lipid-lowering therapy. No thrombophilia-related gene mutation was detected, but a heterozygous mutation in lipoprotein lipase (LPL) gene was identified. His neurological symptoms were managed with short-term anticoagulant therapy and long-term lipid-lowering therapy. This case illustrated the manifestation and potential pathogenesis of CVST and highlighted the essentiality of screening baseline lipid profile and dyslipidemia- and thrombophilia-related gene mutation. Show less
📄 PDF DOI: 10.1055/s-0044-1788043
LPL
M J Emmett, J C F Quintanilha, R P Graf +9 more · 2024 · ESMO real world data and digital oncology · Elsevier · added 2026-04-24
Patients with metastatic colorectal cancer (mCRC) with This study utilized a de-identified mCRC clinicogenomic database from ∼280 US cancer clinics between March 2014 and April 2023. We examined real- Show more
Patients with metastatic colorectal cancer (mCRC) with This study utilized a de-identified mCRC clinicogenomic database from ∼280 US cancer clinics between March 2014 and April 2023. We examined real-world progression-free survival (rwPFS) and overall survival (rwOS) between patients with and those without pre-specified genomic alterations (PSGAs) by Cox models and an adjusted risk score. Genomic alterations were also compared between samples collected before and after EGFR mAb therapy. Nearly, one-third of microsatellite stable (MSS) Detection of genomic resistance alterations in MSS Show less
📄 PDF DOI: 10.1016/j.esmorw.2024.100036
FGFR1
Peng Shu, Jiaxin Mo, Zunjiang Li +3 more · 2024 · Aging · Impact Journals · added 2026-04-24
Application of retinol (Vitamin A, VA) in skincare is limited for instability, poor water solubility, and skin intolerance that combats skin aging. We employed computer-aided virtual screening and cel Show more
Application of retinol (Vitamin A, VA) in skincare is limited for instability, poor water solubility, and skin intolerance that combats skin aging. We employed computer-aided virtual screening and cell experiments with transcriptomics, thereby unveiling the comprehensive gene expression and regulation pathway of photoaging HaCaT cell treated with ferulic acid (FA) in synergizing with VA. Through network pharmacology analysis, the combined use of VA and FA exhibited highly correlated cross-targets with skin aging acting on EGFR, PTPN1, ESR2, GSK3B, BACE1, PYGL, PTGS2 and APP. The indicators of oxidative stress, such as SOD, GSH, MDA, CAT and ROS in HaCaT cells after co-administration, were significantly improved from those in photoaging group ( Show less
📄 PDF DOI: 10.18632/aging.205749
BACE1